Table 3 The Comparison of the Biochemical Values of the Groups
From: Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis
Groups | T. billirubin mean ± sd median | D. Billirubin mean ± sd median | ALT mean ± sd median | AST mean ± sd median | ALP mean ± sd median | GGT mean ± sd median | |
|---|---|---|---|---|---|---|---|
Group 1 n = 7 | Initial | *4.6 ± 3.2 4.6 | *3.9 ± 2.5 4 | *119.4 ± 56.4 80 | *167 ± 68.4 197 | *1148 ± 300 750 | ◆ 4414 ± 186.3 110 |
Posttreatment | 1.29 ± 0.82 2.5 | 0.53 ± 0.27 0.3 | 53 ± 18.5 54 | 75 ± 28.1 58 | 556 ± 196.5 324 | 150.7 ± 61.5 71 | |
Group 2 n = 5 | Initial | **2.52 ± 1.07 1.45 | **1.42 ± 0.45 0.25 | **172.7 ± 57.6 92 | **155.2 ± 68 93 | **393.5 ± 44.7 381 | ◆◆ 67.7 ± 25 49 |
Control | 4.37 ± 2.21 0.3 | 2.97 ± 1.75 0.1 | 123.2 ± 18.5 98 | 152.7 ± 47 116.5 | 435.7 ± 37.5 311 | 73.2 ± 24.6 51 |